{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:35:46Z","timestamp":1761989746026,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jval.2015.11.014","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T16:33:18Z","timestamp":1452789198000},"page":"239-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States"],"prefix":"10.1016","volume":"19","author":[{"given":"Carl V.","family":"Asche","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Zografos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenny M.","family":"Norlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill","family":"Urbanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Mamay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Makin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Erntoft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionne M.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mark Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2015.11.014_bib1","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jaad.2012.09.053","article-title":"Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation","volume":"68","author":"Berman","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib2","first-page":"1125","article-title":"Review of actinic keratosis, part I: etiology, epidemiology and clinical presentation","volume":"9","author":"Goldberg","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.12968\/bjon.2012.21.Sup10.S27","article-title":"Management of patients with actinic keratoses","volume":"21","author":"Hepplewhite","year":"2012","journal-title":"Br J Nurs"},{"key":"10.1016\/j.jval.2015.11.014_bib4","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2174\/1872213X11307020008","article-title":"Actinic keratosis: review of the literature and new patents","volume":"7","author":"Cantisani","year":"2013","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"10.1016\/j.jval.2015.11.014_bib5","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/jid.2013.134","article-title":"Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study","volume":"133","author":"Flohil","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib6","first-page":"2","article-title":"Risk factors for actinic keratosis in eight European centres: a case-control study","volume":"167","author":"Traianou","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib7","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0190-9622(88)70270-4","article-title":"Skin cancer in a Queensland population","volume":"19","author":"Green","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib8","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/bjc.1996.535","article-title":"Non-melanoma skin cancer and solar keratoses II analytical results of the South Wales Skin Cancer Study","volume":"74","author":"I","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jval.2015.11.014_bib9","doi-asserted-by":"crossref","first-page":"e19907","DOI":"10.1371\/journal.pone.0019907","article-title":"Actinic skin damage and mortality\u2013the First National Health and Nutrition Examination Survey Epidemiologic Follow-Up Study","volume":"6","author":"He","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2015.11.014_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archderm.142.6.722","article-title":"Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: results from the Prevalence of Actinic Keratoses Italian Study, 2003\u20132004","volume":"142","author":"Naldi","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2133.1994.tb08544.x","article-title":"Epidemiology of solar keratoses","volume":"131","author":"Frost","year":"1994","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib12","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jaad.2012.10.001","article-title":"The importance of early diagnosis and treatment of actinic keratosis","volume":"68","author":"Rigel","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib13","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2217\/fon.11.70","article-title":"Field cancerization in the GI tract","volume":"7","author":"Graham","year":"2011","journal-title":"Future Oncol"},{"key":"10.1016\/j.jval.2015.11.014_bib14","first-page":"1727","article-title":"A genetic explanation of Slaughter\u2019s concept of field cancerization: evidence and clinical implications","volume":"63","author":"Braakhuis","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jval.2015.11.014_bib15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","article-title":"Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin","volume":"6","author":"Slaughter","year":"1953","journal-title":"Cancer"},{"key":"10.1016\/j.jval.2015.11.014_bib16","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1517\/14656566.2012.716039","article-title":"Pharmacotherapy of actinic keratosis: an update","volume":"13","author":"Berman","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jval.2015.11.014_bib17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/archderm.1991.01680060103013","article-title":"Malignant potential of actinic keratoses and the controversy over treatment: a patient-oriented perspective","volume":"127","author":"Dodson","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib18","first-page":"651","article-title":"European Skin Academy.Development of a treatment algorithm for actinic keratoses: a European Consensus","volume":"18","author":"Stockfleth","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1524-4725.2000.99197.x","article-title":"The treatment of actinic keratoses: an update and comparison","volume":"26","author":"Dinehart","year":"2000","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jval.2015.11.014_bib20","first-page":"154","article-title":"Efficacy and safety of ingenol mebutate 0.015% gel 3 weeks after cryosurgery of actinic keratosis: 11-week results","volume":"13","author":"Berman","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib21","first-page":"35","article-title":"Non-adherence to topical treatments for actinic keratosis","volume":"8","author":"Shergill","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.jval.2015.11.014_bib22","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.ejca.2012.01.003","article-title":"Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989\u20132008","volume":"48","author":"Hollestein","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jval.2015.11.014_bib23","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/jid.2010.58","article-title":"Incidence and trends of cutaneous malignancies in the Netherlands, 1989\u20132005","volume":"130","author":"Holterhues","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib24","first-page":"294","article-title":"What is the role of field-directed therapy in the treatment of actinic keratosis? Part 2: commonly used field-directed and lesion-directed therapies","volume":"89","author":"Berman","year":"2012","journal-title":"Cutis"},{"key":"10.1016\/j.jval.2015.11.014_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clindermatol.2009.06.009","article-title":"Actinic keratosis: facts and controversies","volume":"28","author":"Ko","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib26","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1067\/mjd.2000.103339","article-title":"The risk of progression to invasive disease","volume":"42","author":"Glogau","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib27","unstructured":"The Society for Investigative Dermatology and The American Academy of Dermatology Association. The burden of skin diseases: 2005. Available from: http:\/\/www.lewin.com\/~\/media\/Lewin\/Site_Sections\/Publications\/april2005skindisease.pdf. [Accessed April 09, 2015]."},{"key":"10.1016\/j.jval.2015.11.014_bib28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2133.2006.07483.x","article-title":"Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma","volume":"155","author":"Caekelbergh","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib29","first-page":"23","article-title":"Pharmacoeconomic analysis of the treatment of multiple actinic keratoses","volume":"7","author":"Gold","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jval.2015.11.014_bib30","first-page":"8","article-title":"A survey of office visits for actinic keratosis as reported by NAMCS, 1990\u20131999. National Ambulatory Medical Care Survey","volume":"70","author":"Gupta","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.jval.2015.11.014_bib31","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/09546630902887211","article-title":"An economic evaluation of topical treatments for actinic keratosis","volume":"20","author":"Muston","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jval.2015.11.014_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00019053-200927060-00002","article-title":"Pharmacoeconomic considerations in treating actinic keratosis","volume":"27","author":"Neidecker","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2015.11.014_bib33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2165\/11538670-000000000-00000","article-title":"Cost effectiveness of imiquimod 5% cream with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model","volume":"28","author":"Wilson","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2015.11.014_bib34","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1111170","article-title":"Ingenol mebutate gel for actinic keratosis","volume":"336","author":"Lebwohl","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jval.2015.11.014_bib35","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D\u2019Agostino","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.jval.2015.11.014_bib36","doi-asserted-by":"crossref","first-page":"757","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00064","article-title":"Estimating causal effects from large data sets using propensity scores","volume":"127","author":"Rubin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jval.2015.11.014_bib37","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/0895-4356(89)90118-2","article-title":"Risk adjustment in claims-based research: the search for efficient approaches","volume":"42","author":"Roos","year":"1989","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jval.2015.11.014_bib38","first-page":"229","article-title":"Complications, comorbidities, and mortality: improving classification and prediction","volume":"32","author":"Roos","year":"1997","journal-title":"Health Serv Res"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301515051372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301515051372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T01:52:45Z","timestamp":1537062765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301515051372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1098301515051372"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2015.11.014","relation":{},"ISSN":["1098-3015"],"issn-type":[{"type":"print","value":"1098-3015"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2015.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}